Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana and Kentucky launched a program Thursday allowing patients in Washington state and Hawaii to obtain abortion medications in advance for future use. The initiative, called "Just In Case Abortion Pills," enables individuals to have mifepristone and misoprostol on hand to end an early pregnancy when needed. It marks the first time a Planned Parenthood affiliate is offering what healthcare providers call the "advance provision" of abortion medication.
The program operates at 16 health centers across the two states, where patients can receive prescriptions during same-day appointments. Those adding the service to another visit, such as a well-check or STI test, will pay $100, while standalone appointments cost $150; financial assistance programs are available for those who cannot afford the fee. The medications have a shelf life of approximately two years depending on the brand, with expiration dates printed on packaging.
What the Right Is Saying
Republican Senator Cindy Hyde-Smith of Mississippi, who chairs the Senate Pro-Life Caucus, has called advance provision practices "stockpiling." At a 2024 congressional hearing with then-FDA Commissioner Robert Califf, she expressed alarm at patients obtaining abortion medications without ongoing doctor oversight. "It blows me away that you can get this with no doctor oversight, and it is a drug that will literally cause you intentionally to have an abortion," Hyde-Smith said.
Anti-abortion advocates view advance provision as circumventing safeguards they believe should exist around abortion access. The Republican-led Congress succeeded in cutting Planned Parenthood off from Medicaid funding for one year in 2024, though that funding is set to be reinstated in July unless Congress passes new legislation blocking it.
What the Left Is Saying
Rebecca Gibron, president and CEO of Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana and Kentucky, said the organization decided to offer advance provision as evidence supporting the model grew. "With supportive policy environments in Washington and in Hawai'i, this really is the right time for us to step into this space," she said.
Dr. Colleen McNicholas, chief of medical affairs at the same Planned Parenthood affiliate, emphasized that providers remain available throughout a patient's experience with the medication. "We are still available to them as their provider to answer those questions, to review — how do I know how far along I am? What do we expect?" she said.
Elisa Wells, co-founder of Plan C, a website about medication abortion, said having Planned Parenthood offer advance provision is significant because the organization has "trust and name recognition." She noted that Hawaii and Washington's geography can make accessing care quickly challenging. Anna Fiastro, a research scientist at the University of Washington School of Medicine, pointed to World Health Organization guidance supporting self-managed use of these medicines through the first trimester. "These medicines are available over the counter in other countries, and so they're very safe, they're very effective," she said.
What the Numbers Show
The two medications used together for abortion—mifepristone and misoprostol—are legal for patients to have on hand in 49 states. Louisiana made both medications controlled substances in 2024, making it the only state where advance provision is not permitted under law.
Several ongoing legal challenges could affect future access. The Supreme Court has put any immediate changes to mifepristone rules on hold while a case brought by Louisiana against FDA regulations allowing remote prescribing and mail delivery proceeds through lower courts. Providers report an uptick in requests for advance prescriptions following news about the Louisiana litigation, according to Wells of Plan C.
Telehealth organizations have offered abortion medication prescriptions in advance for several years before this Planned Parenthood initiative. Research indicates demand has grown particularly among residents of states with abortion bans, where accessing care quickly can require significant travel.
The Bottom Line
The Planned Parenthood program represents an expansion of medication abortion access through a model that reproductive rights advocates say addresses geographic and timing barriers. Legal challenges to mifepristone regulations remain unresolved, creating uncertainty about future availability. Patients seeking advance prescriptions cite concerns about potential court decisions limiting mail-order access as motivation for obtaining medications now while they remain available.